Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.73 HKD | -.--% | -2.67% | -18.89% |
Apr. 01 | PuraPharm's Net Loss Shrinks in 2023; Revenue Falls 9% | MT |
Mar. 28 | PuraPharm Corporation Limited Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2021 | 660M 84.31M | Sales 2022 | 448M 57.27M | Capitalization | 506M 64.64M |
---|---|---|---|---|---|
Net income 2021 | -122M -15.59M | Net income 2022 | -120M -15.34M | EV / Sales 2021 | 1.14 x |
Net Debt 2021 | 436M 55.72M | Net Debt 2022 | 427M 54.62M | EV / Sales 2022 | 2.08 x |
P/E ratio 2021 |
-2.62
x | P/E ratio 2022 |
-4.2
x | Employees | 662 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 47.06% |
1 week | -2.67% | ||
Current month | -12.05% | ||
1 month | -12.05% | ||
3 months | -17.05% | ||
6 months | -27.72% | ||
Current year | -18.89% |
Managers | Title | Age | Since |
---|---|---|---|
Yu Ling Chan
CEO | Chief Executive Officer | 63 | 98-05-04 |
Hang Woon Ma
SAM | Sales & Marketing | - | - |
Pui Hung
HRO | Human Resources Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Kwok Wah Ho
BRD | Director/Board Member | 65 | 15-06-11 |
Lim Kin Leung
BRD | Director/Board Member | 70 | 15-06-11 |
Yu Ling Chan
CEO | Chief Executive Officer | 63 | 98-05-04 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-30 | 0.73 | -.--% | 14,000 |
24-04-29 | 0.73 | -2.67% | 402,500 |
24-04-26 | 0.75 | -.--% | 70,000 |
24-04-25 | 0.75 | -.--% | 0 |
24-04-24 | 0.75 | +1.35% | 208,000 |
Delayed Quote Hong Kong S.E., April 30, 2024 at 04:08 am EDT
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-18.89% | 36.87M | |
+39.33% | 6.11B | |
-18.38% | 4.35B | |
-9.17% | 3.18B | |
+3.98% | 3.16B | |
-3.41% | 2.51B | |
+48.74% | 1.98B | |
-4.82% | 1.74B | |
-1.24% | 1.63B | |
-8.96% | 1.6B |
- Stock Market
- Equities
- 1498 Stock